ESBL, plasmidic AmpC, and associated quinolone resistance determinants in coliforms isolated from hospital effluent: First report of qnrB2, qnrB9, qnrB19, and blaCMY-4 in Algeria
- Anssour, L. 2
- Messai, Y. 2
- Derkaoui, M. 2
- Alouache, S. 23
- Estepa, V. 1
- Somalo, S. 1
- Torres, C. 1
- Bakour, R. 2
-
1
Universidad de La Rioja
info
-
2
University of Sciences and Technology Houari Boumediene
info
University of Sciences and Technology Houari Boumediene
Argel, Argelia
-
3
École Nationale Supérieure des Sciences de la Mer et de l'Aménagement du Littoral
info
École Nationale Supérieure des Sciences de la Mer et de l'Aménagement du Littoral
Argel, Argelia
ISSN: 1120-009X
Año de publicación: 2014
Volumen: 26
Número: 2
Páginas: 74-79
Tipo: Artículo
beta Ver similares en nube de resultadosOtras publicaciones en: Journal of Chemotherapy
Proyectos relacionados
Resumen
The characterization of extended-spectrum beta-lactamases, plasmidic AmpC (pAmpC), and associated plasmid-mediated quinolone resistance (PMQR) determinants in cefotaxime-resistant coliforms isolated from hospital effluent in Algiers showed bla CTX-M genes in 89%, bla TEM-1 in 79•8%, and pAmpC genes (bla CIT) in 2•7% isolates. Association of IS Ecp1B with bla CTX-M was found in all CTX-M+ isolates, and 97•2% harboured class 1 integrons. Sequencing showed bla CTX-M-15, bla CTX-M-3, and bla CMY-4 genes. bla CTX-M-3 and bla CTX-M-15 were located in Inc L/M conjugative plasmids. The PMQR determinants identified were qnrB1, qnrB2, qnrB9, qnrB19, qnrS2, and aac(6')-Ib-cr. qnrB2, qnrB9, qnrB19, and bla CMY-4are described for the first time in Algeria and qnrB19 for the first time in non-clinical environments. This study highlights the major potential role of hospital effluents as providers of resistance genes to natural environments. © 2014 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.